Correlation Between Cementos Pacasmayo and BioNTech

Can any of the company-specific risk be diversified away by investing in both Cementos Pacasmayo and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cementos Pacasmayo and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cementos Pacasmayo SAA and BioNTech SE, you can compare the effects of market volatilities on Cementos Pacasmayo and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cementos Pacasmayo with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cementos Pacasmayo and BioNTech.

Diversification Opportunities for Cementos Pacasmayo and BioNTech

0.77

Correlation Coefficient

Cementos Pacasmayo  BioNTech

Poor diversification

The 3 months correlation between Cementos and BioNTech is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Cementos Pacasmayo SAA and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Cementos Pacasmayo is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cementos Pacasmayo SAA are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Cementos Pacasmayo i.e., Cementos Pacasmayo and BioNTech go up and down completely randomly.

Pair Corralation between Cementos Pacasmayo and BioNTech

Given the investment horizon of 90 days Cementos Pacasmayo SAA is expected to generate 0.57 times more return on investment than BioNTech. However, Cementos Pacasmayo SAA is 1.75 times less risky than BioNTech. It trades about 0.14 of its potential returns per unit of risk. BioNTech SE is currently generating about 0.05 per unit of risk. If you would invest  550.00  in Cementos Pacasmayo SAA on May 5, 2025 and sell it today you would earn a total of  86.00  from holding Cementos Pacasmayo SAA or generate 15.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Cementos Pacasmayo SAA  vs.  BioNTech SE

Cementos Pacasmayo SAA

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Cementos Pacasmayo SAA are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Cementos Pacasmayo exhibited solid returns over the last few months and may actually be approaching a breakup point.

BioNTech SE

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BioNTech may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Pair Trading with Cementos Pacasmayo and BioNTech

The main advantage of trading using opposite Cementos Pacasmayo and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cementos Pacasmayo position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.

The idea behind Cementos Pacasmayo SAA and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.